PORTFOLIO CHANGE ALERT
After sleeping on it, I've decided to pull AVNA from my portfolio. As I previously noted, its status as a biotech is questionable. I also remembered that a spin-off of one of its investments will soon take place (and there may be other spin-offs during the year), unnecessarily complicating contest record-keeping.
To replace AVNA, I've chosen SOMX, a recent IPO on rkrw's list. Checking out SOMX, I noticed that one of its lead drugs is targeted at pathological gambling. Coincidentally, I'm currently reading a newly-published book, written by a friend, about his struggle with addictive gambling ("Six To Five Against" by Burt Dragin). Also, SOMX's CEO is Kenneth Cohen and I've always done well with companies headed by a Cohen (or a derivation such as Kahn; e.g., the Pokemon King). Thus, with so many factors in its favor (not least of which is its selection by legendary biotech stockpicker, rkrw), SOMX has got to be a lock.
After the change, here's my revised 2006 Biotech Charity list:
ARQL: 10%: 1,633.99 shares
AXYX: 10%: 12,048.19 shares
CRIS: 15%: 4,213.48 shares
DVAX: 15%: 3,562.95 shares
GNTA: 10%: 6,849.32 shares
RNAI: 10%: 3,300.33 shares
SOMX: 10%: 1,005.03 shares
TELK: 10%: 588.58 shares
VIAC: 10%: 1,779.36 shares
HAPPY NEW YEAR!
Bulba
(John: Sorry for causing you extra work.) |
